
This section is about Pharmaceutical Regulatory Affairs.
Contributions from members are very welcome. Every article is published with full credentials about Author. Register as the member and publish your professional article.
|
|
Regulatory Affairs News
|
|
Written by Jennifer Miller
|
|
Wednesday, 11 June 2008 |

Are Nanotubes related to Mesothelioma?
Nanotechnology is the emerging scientific field which includes the study of small, thin, carbon-based materials known as nanotubes (also called CNTs), which are becoming widely used in a plethora of products ranging from technologically advanced items utilized by NASA to everyday items used in the home. These nanotubes are increasingly popular due to their light weight and supreme strength, which is said to be stronger than steel.
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Linda Bren
|
|
Monday, 02 June 2008 |
|
Bacteria-Eating Virus Approved as Food Additive
Not all viruses harm people. The Food and Drug Administration has approved a mixture of viruses as a food additive to protect people. The additive can be used in processing plants for spraying onto ready-to-eat meat and poultry products to protect consumers from the potentially life-threatening bacterium Listeria monocytogenes (L. monocytogenes).
Bacteriophages are found in the environment. "We're routinely exposed to bacteriophages," says Zajac. "They are found in soil and water, and they are part of the microbial population in the human gut and oral cavity."
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Martina Ivanisevic
|
|
Monday, 12 May 2008 |
Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and response

Drug approvals in the US and Europe have become subject to approval delays, rising requests for further clinical data, and greater chances of rejection. Regulators are currently attempting to reconfigure review processes in order to minimize delays in recognition of the potential mass benefit of new applications.
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Miguel Gorjão-Henriques
|
|
Tuesday, 29 April 2008 |
Pirates and Corsairs - The difficult equation Pharma-Parallel Trade“In the legal debate (…), with a little bit of imagination, the undertakings who dedicate themselves to parallel trade could be compared with the pirates and those who defend their intellectual property rights could be compared with the corsairs, who received the “corsair patent” from their Government to attack the ships of the enemy countries.
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Brad Clemmons
|
|
Saturday, 02 February 2008 |
First FarmavitaR+ / regulanet conference

More
than 25 participants met recently in Zagreb to explore and prepare for
collaborations with the associates of FarmavitaR+ (FvR+) in
Central, Eastern and South-eastern Europe.
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Administrator
|
|
Saturday, 02 February 2008 |
Marketing Authorisation for Medicines via Centralised Procedure in Turkey
Marketing authorisation could be laso granted for Turkey to comapnies on-going cantalised procedure by EMEA, according to investigation of FarmavitaR+ consultant from Istanbul, Turkey.
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Mgr. Mihaela David
|
|
Tuesday, 22 January 2008 |
Romania - Tariffs for
products authorised through mutual recognition procedure or decentralised
procedure
Ther Framavita.Net members and visitors please be informed that in Romania for
registration of medicinal product two separate fees should be paid:
-one is called tax for
evaluation and is in amount of 1000 euros, no matter the type of registration
-the other one is a fee for
registration which depends on the type of the application (registration,
variation by national procedure/ MRP/ DCP).
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by Eva Bolger
|
|
Monday, 10 December 2007 |
New Guidelines about Administrative fees in the Czech Republic
As of December 1 2007 this new guideline for admistraive fees supersedes guideline UST 29 published in January 2007.
Please, contact us for
regulatory affairs support in Czech R., Slovak R., Hungary, Croatia,
Serbia, Montenegro, Macednia, Albania, Bulgaria, Romania and Turkey.
|
|
Read more...
|
|
|
Regulatory Affairs News
|
|
Written by shweta
|
|
Tuesday, 06 November 2007 |
Regulatory about cosmetic ingredients
Many of the ingredients used in the cosmetic products are
actually industrial strength chemicals, solvents and
petroleum by-products. This is even true for many of the most expensive
products available and products being promoted as "natural". The truth is that many of the
ingredients used widely by cosmetic industry , reason of being used is
not that they are good for your skin.
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 1 - 12 of 23 |